Oct 14 (Reuters)- Chordia Therapeutics Inc. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Aug 31, 2025 Aug 31, 2024 Aug 31, 2026 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Operating loss 1.79 loss 1.80 loss 2.01 Recurring loss 1.77 loss 1.82 loss 1.96 Net loss 1.79 loss 1.83 loss 1.96 EPS loss 26.03 yen loss 31.11 yen loss 28.41 yen Ann Div NIL NIL NIL -Q2 Div NIL NIL NIL -Q4 Div NIL NIL NIL NOTE - Chordia Therapeutics Inc.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T